Journal of Clinical Endocrinology & Metabolism, Vol 66, 815-822, Copyright © 1988 by Endocrine Society

ARTICLES

Human epidermal keratinocytes in culture convert thyroxine to 3,5,3'- triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin

MM Kaplan, CY Pan, PR Gordon, JK Lee and BA Gilchrest
Department of Medicine, New England Medical Center Hospital, Boston, Massachusetts 02111.

Cultured human keratinocytes converted T4 to T3 by type II iodothyronine deiodination. Homogenates of keratinocytes cultured from neonatal foreskin or adult arm skin had similar mean T4 5'-deiodinating activities. Conversion of T4 to T3 by intact cells was demonstrable in cultures from neonatal and adult donors. Only phenolic ring deiodination occurred in the cultured cells and their homogenates, the apparent Michaelis constant for T4 was 12 nmol/L, and T4 and rT3 each inhibited 5'-deiodination of the other. T4 5'-deiodination was unaffected by addition to the assay mixture of 1 mumol/L T3, but was inhibited less than 10% by 1 mmol/L 6-n-propyl-2-thiouracil, 50% by 270 nmol/L iopanoic acid, 50% by 9.4 mumol/L 3,5-diiodo- 3',5'-dimethyl-L- thyronine, and 33% by 42 mumol/L amiodarone. When keratinocytes were cultured for 3-4 days in medium containing iodothyronine-free fetal calf serum, the T4 5'-deiodination rates in homogenates doubled; this increase was prevented by restoring a physiological free T4 concentration, but not by a supraphysiological T3 concentration. Homogenates of fresh whole skin or fetal cadaveric epidermis did not convert T4 to T3 in measureable amounts, although one epidermal homogenate had low level T3 typrosyl-ring deiodinating activity. These results suggest that human epidermal type II iodothyronine deiodination in man might conceivably contribute to the intracellular T3 content of the skin and even to serum T3 concentrations, especially in hypothyroidism.

This article has been cited by other articles:

				J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				M. Murakami, O. Araki, Y. Hosoi, Y. Kamiya, T. Morimura, T. Ogiwara, H. Mizuma, and M. Mori Expression and Regulation of Type II Iodothyronine Deiodinase in Human Thyroid Gland Endocrinology, July 1, 2001; 142(7): 2961 - 2967. [Abstract] [Full Text] [PDF]

				A. Slominski and J. Wortsman Neuroendocrinology of the Skin Endocr. Rev., October 1, 2000; 21(5): 457 - 487. [Abstract] [Full Text]

				C. Buettner, J. W. Harney, and P. R. Larsen The 3'-Untranslated Region of Human Type 2 Iodothyronine Deiodinase mRNA Contains a Functional Selenocysteine Insertion Sequence Element J. Biol. Chem., December 11, 1998; 273(50): 33374 - 33378. [Abstract] [Full Text] [PDF]

				J. P. Schroder-van der Elst, D. van der Heide, G. Morreale de Escobar, and M. J. Obregon Iodothyronine Deiodinase Activities in Fetal Rat Tissues at Several Levels of Iodine Deficiency: A Role for the Skin in 3,5,3'-Triiodothyronine Economy? Endocrinology, May 1, 1998; 139(5): 2229 - 2234. [Abstract] [Full Text] [PDF]

				G. N. Burrow, D. A. Fisher, and P. R. Larsen Maternal and Fetal Thyroid Function N. Engl. J. Med., October 20, 1994; 331(16): 1072 - 1078. [Full Text]